{"title":"Making Every Penny Count: Kinase Signaling Transduction, Copper Homeostasis, & Nutrient Sensing.","authors":"Donita C Brady","doi":"10.1016/j.jmb.2025.169089","DOIUrl":null,"url":null,"abstract":"<p><p>Dr. Donita C. Brady is the Harrison McCrea Dickson, MD, and Clifford C. Baker, MD Presidential Associate Professor of Cancer Biology at the University of Pennsylvania Perelman School of Medicine. She earned her BS in Chemistry from Radford University and her PhD in Pharmacology from UNC-Chapel Hill before completing postdoctoral training at Duke University with Dr. Christopher Counter. At Penn, Dr. Brady leads a research program pioneeringmetalloallostery, where redox-active metals regulate kinase activity. Her lab investigates the intersection of kinase signaling and copper (Cu) homeostasis, identifying Cu-dependent kinases and developing targeted therapies through drug repurposing and novel drug design. Her work has advanced our understanding of metals in nutrient signaling, energy homeostasis, and cancer metabolism. Dr. Brady has received numerous honors, including being a Pew Biomedical Scholar, a V Foundation Scholar, and the recipient of the Perelman School of Medicine's Michael S. Brown New Investigator Research Award. A dedicated advocate for diversity, equity, inclusion, and accessibility (DEIA), she has spent the past decade addressing barriers to representation in STEM. In 2021, she was appointed the inaugural Assistant Dean for Inclusion, Diversity, and Equity (IDE) in Research Training at Penn, leading efforts to foster an inclusive research environment. For these contributions, she received the 2022 Vanderbilt Basic Science Juneteenth Icon Award and the Penn Biomedical Graduate Studies Cell and Molecular Biology Graduate Group Community Service Award.</p>","PeriodicalId":369,"journal":{"name":"Journal of Molecular Biology","volume":" ","pages":"169089"},"PeriodicalIF":4.7000,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Molecular Biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.jmb.2025.169089","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Dr. Donita C. Brady is the Harrison McCrea Dickson, MD, and Clifford C. Baker, MD Presidential Associate Professor of Cancer Biology at the University of Pennsylvania Perelman School of Medicine. She earned her BS in Chemistry from Radford University and her PhD in Pharmacology from UNC-Chapel Hill before completing postdoctoral training at Duke University with Dr. Christopher Counter. At Penn, Dr. Brady leads a research program pioneeringmetalloallostery, where redox-active metals regulate kinase activity. Her lab investigates the intersection of kinase signaling and copper (Cu) homeostasis, identifying Cu-dependent kinases and developing targeted therapies through drug repurposing and novel drug design. Her work has advanced our understanding of metals in nutrient signaling, energy homeostasis, and cancer metabolism. Dr. Brady has received numerous honors, including being a Pew Biomedical Scholar, a V Foundation Scholar, and the recipient of the Perelman School of Medicine's Michael S. Brown New Investigator Research Award. A dedicated advocate for diversity, equity, inclusion, and accessibility (DEIA), she has spent the past decade addressing barriers to representation in STEM. In 2021, she was appointed the inaugural Assistant Dean for Inclusion, Diversity, and Equity (IDE) in Research Training at Penn, leading efforts to foster an inclusive research environment. For these contributions, she received the 2022 Vanderbilt Basic Science Juneteenth Icon Award and the Penn Biomedical Graduate Studies Cell and Molecular Biology Graduate Group Community Service Award.
期刊介绍:
Journal of Molecular Biology (JMB) provides high quality, comprehensive and broad coverage in all areas of molecular biology. The journal publishes original scientific research papers that provide mechanistic and functional insights and report a significant advance to the field. The journal encourages the submission of multidisciplinary studies that use complementary experimental and computational approaches to address challenging biological questions.
Research areas include but are not limited to: Biomolecular interactions, signaling networks, systems biology; Cell cycle, cell growth, cell differentiation; Cell death, autophagy; Cell signaling and regulation; Chemical biology; Computational biology, in combination with experimental studies; DNA replication, repair, and recombination; Development, regenerative biology, mechanistic and functional studies of stem cells; Epigenetics, chromatin structure and function; Gene expression; Membrane processes, cell surface proteins and cell-cell interactions; Methodological advances, both experimental and theoretical, including databases; Microbiology, virology, and interactions with the host or environment; Microbiota mechanistic and functional studies; Nuclear organization; Post-translational modifications, proteomics; Processing and function of biologically important macromolecules and complexes; Molecular basis of disease; RNA processing, structure and functions of non-coding RNAs, transcription; Sorting, spatiotemporal organization, trafficking; Structural biology; Synthetic biology; Translation, protein folding, chaperones, protein degradation and quality control.